CD109 and central nervous system cancer: In accordance with our findings, high CD109 mRNA expression associated with poorer survival in the data sets of lower grade gliomas (TCGA LGG) and when glioblastoma and lower grade gliomas were combined, but not in glioblastomas alone (TCGA GBM) (Supplemental Figure 1, A–C).